Success in the beef industry is rooted in doing things efficiently and effectively, and a strategic parasite control program is foundational to both, says Abby Blackwell, cattle manager at Tiffany Cattle Company.
With two finishing yards and two starter yards located in central Kansas, Tiffany Cattle Company is committed to innovation and continuous improvement to ensure the operation stays on the leading edge of feedlot management and animal welfare.
Valcor® (doramectin and levamisole injection) is a recent addition to Tiffany Cattle Company’s on-arrival program, and it’s a product that Blackwell and her team have come to appreciate for the convenience and effectiveness that the combination dewormer offers. With Valcor, the team has a single administration type, which simplifies inventory needs.
“It’s our goal to get animals in and out of the chute as fast as possible in order to reduce stress and protect their condition,” Blackwell says. “Valcor helps us do that. It helps us beat the heat in the middle of summer, and we can get cattle processed before it gets to be 80 degrees at 9 a.m. It helps us better balance employee workloads, so that they can get through the yards and perform animal health checks before it gets too hot as well.”
In addition to the time savings that Valcor offers the operation, she appreciates the product administration route. Valcor is administered by injection and has more reliable dosing than pour-on or oral drench, which can lead to greater efficacy.1
“We can control more of the absorption rate when we don’t have to worry about an animal spitting it out or not getting the proper dosage of the product,” she explains. “We make every effort to administer the right amount of Valcor based on animal weight, so we can optimize animal performance in the feedyard.”
Learn more about the benefits of Valcor from the Tiffany Cattle Company team in this video.
IMPORTANT SAFETY INFORMATION: Do not treat cattle with Valcor within 15 days of slaughter. Not for use in female dairy cattle 20 months of age or older, including dry dairy cows; not for use in beef calves less than 2 months of age, dairy calves, and veal calves. Safety has not been evaluated in breeding bulls. Use with caution in cattle treated with cholinesterase inhibitors. This product is likely to cause injection site swelling; tissue damage (including granulomas and necrosis) may occur. These reactions have resolved without treatment. See full prescribing information here.
About Zoetis
Zoetis is the world’s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal illness, supporting veterinarians, livestock producers, and pet owners in over 100 countries. We integrate deep scientific expertise, data-driven R&D, advanced manufacturing, and commercial excellence to deliver meaningful innovation across medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. Guided by our vision to be the most trusted and valued animal health company, Zoetis is committed to setting new standards for the future of animal care through innovation, customer obsession, and purpose-driven colleagues. To learn more, visit Zoetis.com.
